×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modératrice :
Isabelle Ray-Coquard

Intervenants :
Florence Joly
Olivia Le Saux
Stanislas Quesada

Agenda

18:00 Caractérisation et définition de la rechute et de la résistance aux sels de platine
Olivia Le Saux
 
18:20 Stratégie thérapeutique actuelle et à venir (incluant les nouveaux biomarqueurs dans les cancers de l'ovaire en rechute)
Stanislas Quesada
 
18:40 Quelles spécificités du parcours de soins des cancers résistants aux sels de platine
Florence Joly
 
19:00 Débat/Discussion – Réponses aux questions
 

 

Shooting date : 2025-01-22
Last update : 2025-01-28

Suggestions

Wednesday, November 20th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, November 20th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Wednesday, November 20th 2024 from 09am to 10:30am (GMT+1)
New York : Wednesday, November 20th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, November 20th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, November 20th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, November 20th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, November 20th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, November 20th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, November 21st 2024 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, November 21st 2024 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, November 21st 2024 from 02am to 03:30am (GMT+1)
Sydney : Thursday, November 21st 2024 from 03am to 04:30am (GMT+1)
Wellington : Thursday, November 21st 2024 from 05am to 06:30am (GMT+1)

Les iPARP dans le cancer de l’ovaire : biologie, rationnel, traitements actuels et perspectives...

Share
Wednesday, January 8th 2025 from 06:30pm to 07:45pm (GMT+1)
Honolulu : Wednesday, January 8th 2025 from 07:30am to 08:45am (GMT+1)
San Francisco : Wednesday, January 8th 2025 from 09:30am to 10:45am (GMT+1)
New York : Wednesday, January 8th 2025 from 12:30pm to 01:45pm (GMT+1)
Buenos Aires : Wednesday, January 8th 2025 from 02:30pm to 03:45pm (GMT+1)
London / Dublin : Wednesday, January 8th 2025 from 05:30pm to 06:45pm (GMT+1)
Paris / Berlin : Wednesday, January 8th 2025 from 06:30pm to 07:45pm (GMT+1)
Istanbul : Wednesday, January 8th 2025 from 07:30pm to 08:45pm (GMT+1)
Moscou / Dubaï : Wednesday, January 8th 2025 from 09:30pm to 10:45pm (GMT+1)
Bangkok : Thursday, January 9th 2025 from 12:30am to 01:45am (GMT+1)
Shanghai : Thursday, January 9th 2025 from 01:30am to 02:45am (GMT+1)
Tokyo : Thursday, January 9th 2025 from 02:30am to 03:45am (GMT+1)
Sydney : Thursday, January 9th 2025 from 03:30am to 04:45am (GMT+1)
Wellington : Thursday, January 9th 2025 from 05:30am to 06:45am (GMT+1)

Bénéfices de la maintenance par iPARP en 1L du cancer de l’ovaire

Share
Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Honolulu : Wednesday, May 18th 2022 from 07:30am to 09am (GMT+2)
San Francisco : Wednesday, May 18th 2022 from 10:30am to 12pm (GMT+2)
New York : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
Buenos Aires : Wednesday, May 18th 2022 from 02:30pm to 04pm (GMT+2)
Reykjavik : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
London / Dublin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Paris / Berlin : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
Istanbul : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
Moscou / Dubaï : Wednesday, May 18th 2022 from 09:30pm to 11pm (GMT+2)
Bangkok : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
Shanghai : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
Tokyo : Thursday, May 19th 2022 from 02:30am to 04am (GMT+2)
Sydney : Thursday, May 19th 2022 from 04:30am to 06am (GMT+2)
Wellington : Thursday, May 19th 2022 from 06:30am to 08am (GMT+2)

Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire

Share
Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, January 31st 2023 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, January 31st 2023 from 09am to 10:30am (GMT+1)
New York : Tuesday, January 31st 2023 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, January 31st 2023 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, January 31st 2023 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, February 1st 2023 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, February 1st 2023 from 05am to 06:30am (GMT+1)

Cancer de l'ovaire en 1L :

Actualités et options thérapeutiques disponibles en 2023

Share